Rick F Clark - JoVE Visualize

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Leukemia|December 13, 2019

A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignanciesDarren C Phillips, Sha Jin, Gareth P Gregory, et al.

ACS Medicinal Chemistry Letters|July 16, 2021

Balancing Properties with Carboxylates: A Lead Optimization Campaign for Selective and Orally Active CDK9 InhibitorsYunsong Tong, Alan S Florjancic, Rick F Clark, et al.

Plos Neglected Tropical Diseases|March 1, 2019

Discovery of ABBV-4083, a novel analog of Tylosin A that has potent anti-Wolbachia and anti-filarial activityThomas W von Geldern, Howard E Morton, Rick F Clark, et al.

Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Leukemia|December 13, 2019

A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignanciesDarren C Phillips, Sha Jin, Gareth P Gregory, et al.

ACS Medicinal Chemistry Letters|July 16, 2021

Balancing Properties with Carboxylates: A Lead Optimization Campaign for Selective and Orally Active CDK9 InhibitorsYunsong Tong, Alan S Florjancic, Rick F Clark, et al.

Plos Neglected Tropical Diseases|March 1, 2019

Discovery of ABBV-4083, a novel analog of Tylosin A that has potent anti-Wolbachia and anti-filarial activityThomas W von Geldern, Howard E Morton, Rick F Clark, et al.

Pageof 1